BACKGROUND AND AIM OF THE STUDY: Bicuspid aortic valve (BAV) disease is associated with an aortopathy resulting in aneurysmal dilatation spanning the root, ascending, and arch segments. To date, no large series of proximal aortic replacement in this population has been reported. The study aim was to report contemporary surgical outcomes for proximal aortic replacement in BAV disease, and to examine the relationships between valve morphology, valve pathophysiology, and pathology of the thoracic aorta. METHODS: Between September 2005 and December 2009, a total of 100 consecutive patients (mean age 54 +/- 13 years; range: 29-80 years) with BAV and proximal aortic enlargement underwent aortic replacement at a single referral institution. Of these patients, 16% had undergone prior aortic valve replacement (AVR). The aortic repair was individually tailored to treat the aortic valve and thoracic aortic pathology, and included supracoronary ascending aortic (AA) replacement (n = 17), AVR with separate supracoronary AA replacement (n = 39), aortic root replacement (n = 42), and valve-sparing root replacement (n = 2). Concomitant arch replacement was performed in 82 patients (80 hemi-arch, two full arch). Other concomitant cardiac procedures were performed in 28 patients. RESULTS: The 30-day/in-hospital rates of death and stroke were both 1%. The predominant aortic valve pathophysiology was aortic stenosis (AS; 33%), aortic insufficiency (AI; 29%), mixed AS/AI (17%), normally functioning BAV (17%), and unknown (4%). Valve morphology included Sievers Type I, R/L (75%), Type I, R/N (9%), Type I, L/N (2%), Type 0 (7%), and Type II (7%). BAV patients with predominantly AI had more frequent root dilatation (62%) than those with either AS (30%) or normal valve function (35%). Based on BAV morphology, there were no significant differences in maximal thoracic aortic diameters between groups. At a mean follow up of 16 months, there were no late deaths or valve-related complications. CONCLUSION: Proximal aortic replacement in patients with BAV can be performed with low rates of mortality and morbidity. The pathologic anatomy of the thoracic aorta was not predicted by the aortic valve morphology, although dilation of the aortic root was most common in BAV patients with a predominant AI pathophysiology. These findings convey the safety and feasibility of treating concomitant aortopathy, including arch replacement as needed, and may help tailor the specific operation needed to the patient's pathology.
BACKGROUND AND AIM OF THE STUDY: Bicuspid aortic valve (BAV) disease is associated with an aortopathy resulting in aneurysmal dilatation spanning the root, ascending, and arch segments. To date, no large series of proximal aortic replacement in this population has been reported. The study aim was to report contemporary surgical outcomes for proximal aortic replacement in BAV disease, and to examine the relationships between valve morphology, valve pathophysiology, and pathology of the thoracic aorta. METHODS: Between September 2005 and December 2009, a total of 100 consecutive patients (mean age 54 +/- 13 years; range: 29-80 years) with BAV and proximal aortic enlargement underwent aortic replacement at a single referral institution. Of these patients, 16% had undergone prior aortic valve replacement (AVR). The aortic repair was individually tailored to treat the aortic valve and thoracic aortic pathology, and included supracoronary ascending aortic (AA) replacement (n = 17), AVR with separate supracoronary AA replacement (n = 39), aortic root replacement (n = 42), and valve-sparing root replacement (n = 2). Concomitant arch replacement was performed in 82 patients (80 hemi-arch, two full arch). Other concomitant cardiac procedures were performed in 28 patients. RESULTS: The 30-day/in-hospital rates of death and stroke were both 1%. The predominant aortic valve pathophysiology was aortic stenosis (AS; 33%), aortic insufficiency (AI; 29%), mixed AS/AI (17%), normally functioning BAV (17%), and unknown (4%). Valve morphology included Sievers Type I, R/L (75%), Type I, R/N (9%), Type I, L/N (2%), Type 0 (7%), and Type II (7%). BAV patients with predominantly AI had more frequent root dilatation (62%) than those with either AS (30%) or normal valve function (35%). Based on BAV morphology, there were no significant differences in maximal thoracic aortic diameters between groups. At a mean follow up of 16 months, there were no late deaths or valve-related complications. CONCLUSION: Proximal aortic replacement in patients with BAV can be performed with low rates of mortality and morbidity. The pathologic anatomy of the thoracic aorta was not predicted by the aortic valve morphology, although dilation of the aortic root was most common in BAV patients with a predominant AI pathophysiology. These findings convey the safety and feasibility of treating concomitant aortopathy, including arch replacement as needed, and may help tailor the specific operation needed to the patient's pathology.
Authors: Linda A Pape; Thomas T Tsai; Eric M Isselbacher; Jae K Oh; Patrick T O'gara; Arturo Evangelista; Rossella Fattori; Gabriel Meinhardt; Santi Trimarchi; Eduardo Bossone; Toru Suzuki; Jeanna V Cooper; James B Froehlich; Christoph A Nienaber; Kim A Eagle Journal: Circulation Date: 2007-08-20 Impact factor: 29.690
Authors: Gösta B Pettersson; Adrian C Crucean; Robert Savage; Carmel M Halley; Richard A Grimm; Lars G Svensson; Sepehre Naficy; A Marc Gillinov; Jingyuan Feng; Eugene H Blackstone Journal: J Am Coll Cardiol Date: 2008-07-01 Impact factor: 24.094
Authors: Cary W Akins; D Craig Miller; Marko I Turina; Nicholas T Kouchoukos; Eugene H Blackstone; Gary L Grunkemeier; Johanna J M Takkenberg; Tirone E David; Eric G Butchart; David H Adams; David M Shahian; Siegfried Hagl; John E Mayer; Bruce W Lytle Journal: J Thorac Cardiovasc Surg Date: 2008-04 Impact factor: 5.209
Authors: Ryan R Davies; Ryan K Kaple; Divakar Mandapati; Amy Gallo; Donald M Botta; John A Elefteriades; Michael A Coady Journal: Ann Thorac Surg Date: 2007-04 Impact factor: 4.330
Authors: Christian D Etz; Tobias M Homann; Daniel Silovitz; David Spielvogel; Carol A Bodian; Maximilian Luehr; Gabriele DiLuozzo; Konstadinos A Plestis; Randall B Griepp Journal: Ann Thorac Surg Date: 2007-10 Impact factor: 4.330
Authors: Hector I Michelena; Valerie A Desjardins; Jean-François Avierinos; Antonio Russo; Vuyisile T Nkomo; Thoralf M Sundt; Patricia A Pellikka; A Jamil Tajik; Maurice Enriquez-Sarano Journal: Circulation Date: 2008-05-27 Impact factor: 29.690
Authors: Shafie S Fazel; Hari R Mallidi; Richard S Lee; Michael P Sheehan; David Liang; Dominik Fleischman; Robert Herfkens; R Scott Mitchell; D Craig Miller Journal: J Thorac Cardiovasc Surg Date: 2008-04 Impact factor: 5.209
Authors: Oliver K Jawitz; Vignesh Raman; Jatin Anand; Muath Bishawi; Soraya L Voigt; Julie Doberne; Andrew M Vekstein; E Hope Weissler; Joseph W Turek; G Chad Hughes Journal: Eur J Cardiothorac Surg Date: 2020-06-01 Impact factor: 4.191
Authors: Asvin M Ganapathi; Jennifer M Hanna; Matthew A Schechter; Brian R Englum; Anthony W Castleberry; Jeffrey G Gaca; G Chad Hughes Journal: J Thorac Cardiovasc Surg Date: 2014-04-13 Impact factor: 5.209
Authors: Brian Lima; Judson B Williams; S Dave Bhattacharya; Asad A Shah; Nicholas Andersen; Jeffrey G Gaca; G Chad Hughes Journal: Am Surg Date: 2011-11 Impact factor: 0.688
Authors: Jeffrey E Keenan; Hanghang Wang; Brian C Gulack; Asvin M Ganapathi; Nicholas D Andersen; Brian R Englum; Yamini Krishnamurthy; Jerrold H Levy; Ian J Welsby; G Chad Hughes Journal: J Thorac Cardiovasc Surg Date: 2016-08-28 Impact factor: 5.209